Byetta, a drug used to treat adults with type 2 diabetes, has been linked to serious, life-threatening side effects including pancreatic cancer, thyroid cancer, acute hemorrhagic and/or necrotizing pancreatitis.
Byetta Pancreatic Cancer Lawsuit Update 8/27/13: A panel of judges has ruled to consolidate all federal pancreatic cancer lawsuits involving the diabetes drugs Byetta, Januvia, Janumet, and Victoza into a multidistrict litigation (MDL) for pretrial handling in the Southern District of California. These complaints involve allegations that the drugs’ manufacturers failed to adequately research their products before bringing them to market, and were negligent for not warning the public and medical communities about their potential to cause pancreatic cancer. Click here to learn more.
Free Byetta Lawsuit Review: If you or a loved one has developed pancreatic cancer or thyroid cancer while taking Byetta, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.
Breaking News – Michael E. Schmidt Files First Byetta Lawsuit in the Country
AMYLIN PHARMACEUTICALS DIABETES DRUG BYETTA® THE FOCUS OF CALIFORNIA LAWSUIT – (8/19/08) A Virginia man yesterday filed what is believed to be the first personal injury lawsuit stemming from injuries associated with the use of Byetta®, an injectable medication for diabetes.
Byetta and Pancreatic Cancer
Recent studies have determined that Byetta users are at an increased risk of developing pancreatic cancer, the fourth leading cause of cancer death among both men and women in the United States. Each and every year, nearly 50,000 Americans are diagnosed with pancreatic cancer, and almost 40,000 die from the disease. Unfortunately, pancreatic cancer is difficult to diagnose until its later stages, at which point it is often impossible to treat. Signs and symptoms of Byetta pancreatic cancer may include:
- weight loss
- dark urine
- clay-colored stools
- back pain
Early detection of pancreatic cancer is critical, and will greatly improve a patient’s chances of surviving the disease. Byetta users experiencing any of the signs and symptoms listed above should contact their doctor immediately to determine whether they have pancreatic cancer, and what can be done to treat the disease.
Byetta and Thyroid Cancer
In April 2010, reports linking Byetta to thyroid cancer began to surface. Instead of warning consumers about this risk or issuing a Byetta recall, the FDA asked manufacturer Amylin Pharmaceuticals and Eli Lilly to conduct further studies to determine whether Byetta does indeed have the potential to cause thyroid cancer. Signs and symptoms of Byetta thyroid cancer may include:
- thyroid lump (nodule)
- difficulty swallowing
- enlargement of the thyroid gland
- hoarseness or changing voice
- neck swelling
Treatment of Byetta thyroid cancer typically depends on the severity and stage of the disease at the time of diagnosis, as well as the patient’s overall health and medical history. While surgery is usually the first line of defense, a variety of other approaches may be implemented including radioactive iodine treatment, thyroid hormone therapy, external beam radiation therapy, and chemotherapy. In many cases, a combination of these approaches is most successful in treating Byetta thyroid cancer.
Byetta and Acute Pancreatitis
Byetta is a medicine given by injection to help treat adults with type 2 diabetes. Commonly reported side effects of Byetta include nausea, vomiting, diarrhea, indigestion and upper abdominal discomfort. However, the presence of unexplained, severe abdominal pain, with or without nausea and vomiting, raises the suspicion of acute pancreatitis, a potentially serious condition that requires prompt medical attention. Therefore, patients taking Byetta should promptly seek medical care if they experience unexplained severe abdominal pain with or without nausea and vomiting.
Urgent FDA Byetta Pancreatitis Update
As of 8/18/2008, the FDA has reviewed 30 postmarketing reports of acute pancreatitis in patients taking Byetta. Of the most recent 6 cases of hemorrhagic or necrotizing pancreatitis, all patients required hospitalization, two patients died and four patients were recovering at time of reporting. Our law firm continues to be contacted by people claiming to have been diagnosed with pancreatic cancer and thyroid cancer after taking Byetta.
Recently, the FDA has told healthcare professionals to advise patients taking Byetta to seek emergency medical services if they begin to experience unexplained persistent severe abdominal pain which may or may not be accompanied by vomiting. This could be a sign of acute pancreatitis.
IMPORTANT: There are no signs or symptoms that distinguish acute hemorrhagic or necrotizing pancreatitis associated with Byetta from the less severe form of pancreatitis.
In addition, the FDA has recently requested that the manufacturer of Byetta, Amylin Pharmaceuticals, Inc. to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis.
FDA Video: Pancreatitis in Patients Taking Byetta for Diabetes
Below is an excellent video published by the U.S. Food & Drug Administration (FDA), which warns patients of the link between pancreatitis and Byetta.
Read the Full Transcript: Pancreatitis in Patients Taking Byetta for Diabetes
Do I Have a Byetta Lawsuit?
The Defective Drug & Products Liability Litigation Groups at our law firm are an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Byetta lawsuits. We are pursuing individual litigation nationwide and currently accepting new Byetta pancreatic cancer and thyroid cancer cases in all 50 states.
If you or a loved one has developed pancreatic cancer or thyroid cancer while taking Byetta, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.